Juvent

Juvent is a health technology company that delivers clinically validated solutions to improve users' musculoskeletal health. Our patented Micro-Impact Platform has clinically demonstrated the ability to help users manage their osteoporosis and improve bone health, non-invasively. Additionally, our technology helps users decrease joint pain, improve balance, and increase lymphatic drainage. Juvent's Micro-Impact is proving to be an essential ingredient for total health and vitality; a Vitamin of Exerciseˇ A recent Clinical Trial conducted by St. Jude Hospital for Children, published in JAMA Oncology, showed an 11% improvement in BMD in the active group using Juvent's Micro-Impact Platform. (see the study for details) We are committed to helping people live better lives and our vision is to become the global leader in musculoskeletal health Additionally, Juvent has developed a novel bone health supplement, HydroxyBMD. HydroxyBMD offers users a unique microcrystalline hydroxyapatite (calcium/mineral) complex paired with other proprietary ingredients that promote healthy bone. As an AM/PM formula, the AM supplement is calcium-free, giving users and physicians treatment flexibility. For more details see - www.hydroxybmd.com Juvent Health www.juventhealth.com

• Employees 14
• Founded 2011
• Total Funding $1335000